Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Another autoimmune CAR-T death; Treasury zeroes in on China deals

A patient who received Bristol Myers’ zola-cell died 44 days later. Elswehere, Gilead paid nearly $1.3 billion for a potential threat to J&J’s newly approved psoriasis pill.

We haven't written up this one. BioPharma Dive has the full story — the link below goes straight to it.

Read the original at biopharmadive.com →

More in Finance & Markets

More from Monday 26 October →